This document describes the discovery of novel 2,5-disubstituted 1,3,4-oxadiazoles with a benzimidazole backbone as potent inhibitors of the enzyme β-glucuronidase. β-Glucuronidase is involved in various pathological conditions. Derivatives of benzimidazole and 2,5-disubstituted-1,3,4-oxadiazoles have shown various biological activities. The authors synthesized compounds 3a-3r and screened them for β-glucuronidase inhibitory activity, finding IC50 values ranging from 2.14 to 46.14 μM. Molecular docking studies were also performed to explore the binding mode of the new
This document describes the discovery of novel 2,5-disubstituted 1,3,4-oxadiazoles with a benzimidazole backbone as potent inhibitors of the enzyme β-glucuronidase. β-Glucuronidase is involved in various pathological conditions. Derivatives of benzimidazole and 2,5-disubstituted-1,3,4-oxadiazoles have shown various biological activities. The authors synthesized compounds 3a-3r and screened them for β-glucuronidase inhibitory activity, finding IC50 values ranging from 2.14 to 46.14 μM. Molecular docking studies were also performed to explore the binding mode of the new
This document describes the discovery of novel 2,5-disubstituted 1,3,4-oxadiazoles with a benzimidazole backbone as potent inhibitors of the enzyme β-glucuronidase. β-Glucuronidase is involved in various pathological conditions. Derivatives of benzimidazole and 2,5-disubstituted-1,3,4-oxadiazoles have shown various biological activities. The authors synthesized compounds 3a-3r and screened them for β-glucuronidase inhibitory activity, finding IC50 values ranging from 2.14 to 46.14 μM. Molecular docking studies were also performed to explore the binding mode of the new
Discovery of 2,5-Disubstituted 1,3,4-Oxadiazoles with Benzimidazole Backbone
as Potent β-Glucuronidase Inhibitors and In Silico Studies
Nik Khairunissa Nik Abdullah Zawawi1,2, Muhammad Taha1,2, Norizan Ahmat1,2, Noraishah Abdullah1 1 Faculty of Applied Sciences, UiTM Shah Alam, 40450, Shah Alam, Selangor D. E., Malaysia. 2 Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor D. E. Malaysia. *Corresponding author e-mail: chemtitude@yahoo.com
β-Glucuronidase (EC 3.2.1.31) is an inducible enzyme found in anaerobic Escherichia,
Bacteroides, Clostridia and Peptostreptococcus genera which catalyzes the cleavage of β- glucuronosyl-O-bonds [1]. In human body this enzyme is present in fluids and organs such as spleen, serum, bile, urine and kidney [2,3]. β-Glucuronidase improve activity in a diverse pathological circumstances, such as renal diseases [4], epilepsy [5], breast, larynx, testes [6], and in urinary tract infections [7-10]. Moreover, β-glucuronidase has been reported to be released in the synovial fluid in the inflammatory joint diseases, for instance, rheumatoid arthritis [11,12]. Derivatives of benzimidazole are reported to be physiologically and pharmacologically active and find application in treatment of several diseases like epilepsy, diabetes, anti-fertility etc [13,14]. Recently, several researches elucidated that biological profiles of benzimidazole analogues can suitably be modified by the introduction of different heterocyclic moieties to exhibit a broad spectrum of biological activities, i.e. anti-cancer and anti-fungal [15] antiviral [16], antibacterial [17], anthelmintic [18], Anti-inflammatory [19], antihistamines [20], proton pump inhibitors [21], antioxidant [22], antihypertensive [23], anticoagulant [24], antileukaemia [25], and anti-ulcer agents [26]. Benzimidazoles have been applied relatively more as herbicides and in veterinary problems. Many benzimidazoles, for examples, thiabendazole and cambendazole are used efficiently as fungicides, herbicides and antiheliminthies. There are also some fungicides known as 2-aminoimidazolines [27]. While derivatives of 2,5-disubstituted-1,3,4-oxadiazoles reported to show various biological activities such as anti-HIV, antifungal, antibacterial, antitubercular, relaxants, antiinflammatory, virucidal, hypnotic, antimalarial, insecticidal, herbicidal, analgesic, genotoxic, muscle anticonvulsant, anticancer and lipid peroxidation inhibitor [28-42].
Fig. 1. 2,5-disubstitued-1,3,4-oxadiazoles 3a-3r with benzimidazole backbone
In continuation to our efforts in developing β-glucuronidase inhibitors, novel
2,5-disubstitued-1,3,4-oxadiazoles 3a-3r with benzimidazole backbone were synthesized and screened for their β-glucuronidase inhibitory potential (Fig.1). Synthetic compounds 3a-3r demonstrated varying degree of β-glucuronidase inhibitory activity with IC50 values in the range of 2.14 ± 0.03 - 46.14 ± 1.26 µM, when compared to standard substrate D-saccharic acid 1,4-lactone 48.4 ± 1.25 µM. In addition, molecular docking studies were performed to explore the binding mode of newly synthesized derivatives.
References [1] B. Sperker, J.T. Backman, K. Kromer, Clin. Pharmacokinet. 33 (1997) 18-31. [2] W.H. Fishman, Academic Press: New York. (1970) 519.
Design and synthesis of 2,6-di (substituted phenyl) thiazolo (3,2-b) -1,2,4-triazoles as α-glucosidase and α-amylase inhibitors, co-relative Pharmacokinetics and 3D QSAR and risk analysis
The Authoritative Guide to Grapefruit Seed Extract: A Breakthrough in Alternative Treatment for Colds, Infections, Candida, Allergies, Herpes, and Many Other Ailments
Synthesis And Evaluation Of Biscoumarin Analogues Bearing Thiourea Derivatives As Α-Glucosidase Inhibitor Norizan Ahmat*, Nik Khairunissa Nik Abdullah Zawawi, Muhammad Taha, Nor Hadiani Ismail